
Home » Genetron Health Gains CE Mark for COVID-19 Test
Genetron Health Gains CE Mark for COVID-19 Test

Beijing-based Genetron Health has received a CE Mark for its novel coronavirus detection kit.
The polymerase chain-reaction test is designed for use with the company’s Genetron S5 sequencer for testing large-scale samples.
The company has also applied to the FDA for emergency use authorization.
Upcoming Events
-
11Oct
-
16Oct
-
26Oct
-
02Nov
-
08Nov